ORIGINAL PAPER
Awareness, attitude and usage of probiotics for the prevention of antibiotic-associated diarrhoea among caregivers and HCPs in Poland: a cross-sectional study
 
More details
Hide details
1
Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw, Poland
 
2
Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Poland
 
3
General Association for Good Clinical Practice, Warsaw, Poland
 
 
Submission date: 2021-07-12
 
 
Acceptance date: 2021-07-20
 
 
Publication date: 2021-09-29
 
 
Pediatr Pol 2021;96(3):157-161
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
This cross-sectional study aimed at obtaining and analyzing data on awareness, attitude and usage of probiotics for AAD prevention in children among caregivers and doctors in Poland.

Material and methods:
This was a self-administered survey of the children’s caregivers. The survey evaluated caregivers’ opinion on probiotics efficacy in AAD prevention, obtained data about probiotic preparations used and their source of recommendation. Probiotics were classified basing on ESPGHAN recommendations in AAD prevention.

Results:
Probiotics were used in 99.4% (n = 456/463). 190 patients used recommended strains, 162 patients used preparations without proven efficacy. In 87% of cases (n = 397/456), probiotics were advised by doctors, out of which 56% were recommended strains. 32% of them had proven efficacy.

Conclusions:
Our study showed a positive attitude of caregivers towards probiotics for AAD prevention. However, almost half of the preparations were without proven efficacy. HCPs education on the field of probiotics is warranted.
REFERENCES (23)
1.
Araya M, Morelli L, Reid G, et al. Guidelines for the evaluation of probiotics in food. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food 2002; 1-11.
 
2.
Vyas U, Ranganathan N. Probiotics, prebiotics, and synbiotics: gut and beyond. Gastroenterol Res Pract 2012; 2012: 872716.
 
3.
Guarino A, Lo Vecchio A, Canani RB. Probiotics as prevention and treatment for diarrhoea. Curr Opin Gastroenterol 2009; 25: 18-23.
 
4.
Guarino A, Ashkenazi S, Gendrel D, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr 2014; 59: 132-152.
 
5.
McFarland L. Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhoea and the Treatment of Clostridium difficile Disease. Am J Gastroenterol 2006; 101: 812-822.
 
6.
Goldenberg JZ, Lytvyn L, Steurich J, et al. Probiotics for the prevention of pediatric antibiotic‐associated diarrhoea. Cochrane Database of Syst Rev 2015; (12): CD004827.
 
7.
Draper K, Ley C, Parsonnet J. A survey of probiotic use practices among patients at a tertiary medical centre. Benef Microbes 2017; 8: 345-351.
 
8.
Szajewska H, Canani RB, Guarino A, et al. Probiotics for the Prevention of Antibiotic-Associated Diarrhoea in Children. J Pediatr Gastroenterol Nutr 2016; 62: 495-506.
 
9.
Guo Q, Goldenberg JZ, Humphrey C, et al. Probiotics for the prevention of pediatric antibiotic‐associated diarrhoea. Cochrane Database Syst Rev 2019; 4: CD004827.
 
10.
Rijkers GT, Bimmel D, Grevers D, et al. Consumer perception of beneficial effects of probiotics for human health. Benef Microbes 2013; 4: 117-121.
 
11.
Khanpour Ardestani S, Robinson JL, et al. Surveys of parents and clinicians concerning the minimally important difference of probiotic therapy for prevention of paediatric antibiotic-associated diarrhoea. BMJ Open 2019; 9: e024651.
 
12.
Varughese CA, Vakil NH, Phillips KM. Antibiotic-associated diarrhoea: a refresher on causes and possible prevention with probiotics –.
 
13.
continuing education article. J Pharm Pract 2013; 26: 476-482.
 
14.
Oliver L, Rasmussen H, Gregoire M, et al. Health Care Provider’s Knowledge, Perceptions, and Use of Probiotics and Prebiotics. Topics in Clinical Nutrition 2014; 29: 139-149.
 
15.
Fijan S, Frauwallner A, Varga L, et al. Health Professionals’ Knowledge of Probiotics: An International Survey. Int J Environ Res Public Health 2019; 16: 3128.
 
16.
Kotecki JE. Factors Related to Pharmacists’ Over-the-Counter Recommendations. J Community Health 2002; 27: 291-306.
 
17.
Kennedy E, Moody M. An investigation of the factors affecting community pharmacists’ selection of over the counter preparations. Pharm World Sci 2000; 22: 47-52.
 
18.
Venugopalan V, Shriner KA, Wong-Beringer A. Regulatory oversight and safety of probiotic use. Emerg Infect Dis 2010; 16: 1661-1665.
 
19.
Sanco D, Commission E. The use of substances with nutritional or physiological effect other than vitamins and minerals in food supplements study.
 
20.
Szajewska H, Fordymacka A, Bardowski J, et al. Microbiological and genetic analysis of probiotic products licensed for medicinal purposes. Med Sci Monit 2004; 10: Br346-Br350.
 
21.
Aureli P, Fiore A, Scalfaro C, et al. National survey outcomes on commercial probiotic food supplements in Italy. Int J Food Microbiol 2010; 137: 265-273.
 
22.
Kolaček S, Hojsak I, Berni Canani R, et al. Commercial Probiotic Products: A Call for Improved Quality Control. A Position Paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr 2017; 65: 117-124.
 
23.
Wilson Z, Whitehead K. A cross sectional survey to assess healthcare professionals’ attitudes to and understanding of probiotics. Clin Nutr ESPEN 2019; 34: 104-109.
 
Journals System - logo
Scroll to top